You Searched For "third pharmaceutical firm" and got 20 results
Sort By:
COVID-19 vaccine in India: Expert panel to review Pfizer, Serum and Bharat Biotech's emergency use application tomorrow
The Indian arm of US pharmaceutical giant Pfizer had on December 4 sought approval for its va…
PTI
MindTickle is the third SaaS firm from India to enter the unicorn club in 2021
MindTickle, a startup that helps small and large enterprises improve their sales, is the latest ent…
Business is booming for the maker of weight-loss drugs Wegovy and Ozempic — so much so that it is threatening luxury giant LVMH's crown as Europe's most valuable firm
Novo Nordisk's at-home injections are in high demand, but some insurers say they won't cover the hi…
Grace Dean
Here's the data we have so far on the Omicron variant versus our vaccines — what scientists have found, and what remains unanswered
The first lab findings are flying in from scientists around the world. Here's what we know so far o…
Andrew Dunn,Dr. Catherine Schuster-Bruce
Warren Buffett's Berkshire Hathaway reveals new bets on Floor & Decor and Royalty Pharma
The famed investor's company also exited Merck and trimmed several holdings including Visa, Masterc…
Theron Mohamed
The FDA just fully approved Pfizer's COVID-19 vaccine in a move that could lead to more vaccinations
The shift from emergency use to full approval for the Pfizer-BioNTech shot could spur more people t…
Andrew Dunn
HUL becomes third most valued firm by market capitalisation as shares jump
The FMCG major's market valuation rose by Rs 33,817.07 crore to Rs 4,39,188.07 crore, helping it t…
PTI
The FDA will allow COVID-19 booster shots for some people with weakened immune systems
The agency's tweak to the emergency OK for COVID-19 vaccines will allow for booster shots for immun…
Andrew Dunn,Cheryl Teh
Men fill more than 9 in 10 biopharma CEO positions, an inequity that costs women more than $500 million in pay each year
Despite more attention being paid to diversity efforts, 92% of top biopharma CEOs are men, an Insid…
Shelby Livingston,Andrew Dunn
Novavax says its coronavirus vaccine was 90% effective in a large trial, moving the shot a step closer to widespread use
Novavax fell behind rivals like Pfizer and Moderna, and the biotech's launch timeline remains hazy.
Andrew Dunn
Ozempic jabs are 15 times cheaper in China than they are in the US because of Beijing's immense bargaining power with pharma firms and you can buy it online in a 3-step process that takes less than a minute
Drugmakers are willing to swallow hefty price cuts in exchange for access to the world's second-lar…
Kwan Wei Kevin Tan
Inovio sinks 26% after US government decides to discontinue funding for next phase of COVID-19 vaccine trial
"The decision results from the changing environment of COVID-19 with the rapid deployment of vaccin…
Carla Mozée
Warren Buffett's Berkshire Hathaway sold its Biogen stake last quarter - and slashed its pharmaceutical bets
The famed investor's company also sold some Chevron and General Motors shares, and boosted its stak…
Theron Mohamed
Alexion Pharmaceuticals soars 35% after AstraZeneca agrees to $39 billion takeover
The deal has clear gains for both sides, but AstraZeneca's shares slid 6% after news of the UK firm…
Shalini Nagarajan
Cipla only Indian firm to bid for Kremers Urban Pharmaceuticals Inc.
The previous year’s report has said that Kremers Urban Pharmaceuticals Inc had sales of $463 millio…
A pharmaceutical firm with a business model similar to Valeant's is getting slapped
As part of Endo's planned expansion of its International Pharmaceuticals business unit and to furth…
Linette Lopez
Sensex logs gains for third day; RIL spurts post Intel deal
"Another round of shutdowns in a few countries is frightening but hopes of a drug/ vaccine are kee…
PTI
More firms across sectors partially resume operations in lockdown 3.0
"The company has partially resumed operations at its distillery and some of its IMIL bottling plan…
PTI
This VC firm invested in Pharmeasy when it was valued at just $10 million – here’s why it promises to invest in every round even after an IPO
Pharmeasy was one of the startups that got a billion dollar valuation in the unicorn frenzy, where …
The Feds are now asking questions at the biggest middle-man in the pharmaceutical game
On September 12, 2016, the Company received a subpoena duces tecum from the Department of Justice a…